Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression | Zendy

Youlian Zhou | Zendy; Tiying Zheng | Zendy; Huiting Chen | Zendy; Yongqiang Li | Zendy; HongLi Huang | Zendy; Wenji Chen | Zendy; Yanlei Du | Zendy; Jie He | Zendy; Yuyuan Li | Zendy; Jie Cao | Zendy; Yuqiang Nie | Zendy; Yongjian Zhou | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression

Author(s) -

Youlian Zhou,

Tiying Zheng,

Huiting Chen,

Yongqiang Li,

HongLi Huang,

Wenji Chen,

Yanlei Du,

Jie He,

Yuyuan Li,

Jie Cao,

Yuqiang Nie,

Yongjian Zhou

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000495830

Subject(s) - gut flora , adiponectin , biology , fatty liver , steatohepatitis , bacteroides , firmicutes , lactobacillus casei , microbiology and biotechnology , medicine , endocrinology , immunology , disease , insulin resistance , obesity , biochemistry , bacteria , genetics , 16s ribosomal rna , gene , fermentation

Emerging evidence suggests a close link between gut microbiota and non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to investigate the association between gut microbiota and the DNA methylation of adiponectin (an adipocyte-specific adipocytokine) in rats, following diet-induced NAFLD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research